Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Illuminating cognitive dedifferentiation at the end of life.

Dodge HH, Marson DC.

Neurology. 2012 Apr 10;78(15):1110-1. doi: 10.1212/WNL.0b013e31824f80b9. Epub 2012 Apr 4. No abstract available.

PMID:
22491863
2.

Cognitive deficits and the neurobiology of schizophrenia.

Gold JM, Weinberger DR.

Curr Opin Neurobiol. 1995 Apr;5(2):225-30. Review.

PMID:
7620311
3.

Disease progression in pediatric multiple sclerosis: disparities between physical and neurocognitive outcomes.

Yeh EA, Parrish JB, Weinstock-Guttman B.

Expert Rev Neurother. 2011 Mar;11(3):433-40. doi: 10.1586/ern.10.192. Review.

PMID:
21375448
4.

Cerebrovascular disease and cognition in older adults.

Seidel GA, Giovannetti T, Libon DJ.

Curr Top Behav Neurosci. 2012;10:213-41. doi: 10.1007/7854_2011_140. Review.

PMID:
21773915
5.

Chronic cerebral hypoperfusion-related neuropathologic changes and compromised cognitive status: window of treatment.

Farkas E, de Wilde MC, Kiliaan AJ, Luiten PG.

Drugs Today (Barc). 2002 May;38(5):365-76. Review.

PMID:
12532171
6.

Neuroinflammation and cognitive aging.

Ownby RL.

Curr Psychiatry Rep. 2010 Feb;12(1):39-45. doi: 10.1007/s11920-009-0082-1. Review.

PMID:
20425309
7.

Concepts on the prognostic significance of white matter changes.

Kapeller P, Schmidt R.

J Neural Transm Suppl. 1998;53:69-78. Review.

PMID:
9700646
8.

Treatment of cognitive deficits in schizophrenia.

Bowie CR, Harvey PD.

Curr Opin Investig Drugs. 2006 Jul;7(7):608-13. Review.

PMID:
16869112
9.

Cognitive reserve and the neurobiology of cognitive aging.

Whalley LJ, Deary IJ, Appleton CL, Starr JM.

Ageing Res Rev. 2004 Nov;3(4):369-82. Review.

PMID:
15541707
10.

Cognitive and functional changes with aging in schizophrenia.

Friedman JI, Harvey PD, Kemether E, Byne W, Davis KL.

Biol Psychiatry. 1999 Oct 1;46(7):921-8. Review.

PMID:
10509175
11.

Assessment and management of pain in the terminally ill.

Dalal S, Bruera E.

Prim Care. 2011 Jun;38(2):195-223, vii-viii. doi: 10.1016/j.pop.2011.03.004. Review.

PMID:
21628035
12.

[Relation between white matter and cognitive functions].

Tirapu-Ustárroz J, Luna-Lario P, Hernáez-Goñi P, García-Suescun I.

Rev Neurol. 2011 Jun 16;52(12):725-42. Review. Spanish.

13.

Neurocognitive Deficits After Radiation Therapy for Brain Malignancies.

Saad S, Wang TJ.

Am J Clin Oncol. 2015 Dec;38(6):634-40. doi: 10.1097/COC.0000000000000158. Review.

PMID:
25503433
14.

Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics.

Zurkovsky L, Taylor WD, Newhouse PA.

Biochem Pharmacol. 2013 Oct 15;86(8):1133-44. doi: 10.1016/j.bcp.2013.07.032. Epub 2013 Aug 8. Review.

15.

The concept of vascular cognitive impairment.

Bowler JV.

J Neurol Sci. 2002 Nov 15;203-204:11-5. Review.

PMID:
12417350
16.

The relationship between depression and cognitive deficits.

Papazacharias A, Nardini M.

Psychiatr Danub. 2012 Sep;24 Suppl 1:S179-82. Review.

17.

[Before dementia--early features in Alzheimer's disease].

Pulliainen V, Kuikka P.

Duodecim. 1998;114(1):21-30. Review. Finnish. No abstract available.

PMID:
10895463
18.

[Parkinson syndrome and cognitive disorders].

Szirmai I, Kovács T.

Ideggyogy Sz. 2002 Jul 20;55(7-8):220-5. Review. Hungarian.

PMID:
12201229
19.

The effect of white matter lesions on cognition in the elderly--small but detectable.

Frisoni GB, Galluzzi S, Pantoni L, Filippi M.

Nat Clin Pract Neurol. 2007 Nov;3(11):620-7. Review.

PMID:
17982432
20.

Brain atrophy and cognitive impairment in multiple sclerosis: a review.

Lanz M, Hahn HK, Hildebrandt H.

J Neurol. 2007 May;254 Suppl 2:II43-8. Review. Erratum in: J Neurol. 2008 Feb;255(2):309-10.

PMID:
17503128

Supplemental Content

Support Center